BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE) — FDA Approval ANDA077646 (PADAGIS US)
BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE) — FDA Approval ANDA077646 (PADAGIS US) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BROMOCRIPTINE MESYLATE; Active ingredients: BROMOCRIPTINE MESYLATE; Application number: ANDA077646.
| Brand name | BROMOCRIPTINE MESYLATE |
|---|---|
| Active ingredients | BROMOCRIPTINE MESYLATE |
| Application number | ANDA077646 |
| Sponsor | PADAGIS US |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20081001 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →